InvestorsHub Logo
icon url

ORBAPU

09/06/23 4:56 PM

#415080 RE: Number sleven #415078

“The relationship between higher concentrations of EPA and a decreased risk for incident all-cause dementia was significant among APOE e4 noncarriers (Model 2: HR = 0.76, 95% CI 0.61, 0.94) but not among APOE e4 carriers (Table S4). Furthermore, higher concentrations and higher proportions of EPA were associated with a decreased risk for incident AD dementia among APOE e4 noncarriers (concentrations, Model 2: HR = 0.66, 95% CI 0.51, 0.84; proportions, Model 2: HR = 0.80, 95% CI 0.65, 0.99) but not among APOE e4 carriers”

Findings from this study may be of some concern because I believe BRAVE includes APOE e4 carriers.
icon url

ramfan60

09/06/23 5:03 PM

#415081 RE: Number sleven #415078

Quite the irony Sleven......so many contributions from German thought leaders and institutions and they would clearly understand the benefits of EPA and we can't get Germany health to cover V.................. yet!